Preoperative serum C-reactive protein level in non-small cell lung cancer.

Anticancer Res

Department of Cardiovascular, Thoracic and General Surgery, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.

Published: August 2007

AI Article Synopsis

Article Abstract

Unlabelled: We evaluated the significance of the preoperative serum C-reactive protein (CRP) level as a prognostic indicator in patients with non-small cell lung cancer (NSCLC).

Patients And Methods: Two hundred and three patients who had undergone a curative resection of NSCLC were retrospectively reviewed.

Results: The proportion of the tumor size over 3 cm per patient in the CRP-positive group (> or =0.5 mg/dL: n=38) was significantly higher than that in the CRP-negative group (<0.5 mg/dL: n = 165). The proportion of the adenocarcinoma in CRP-positive group was significantly lower than that in CRP-negative group. The overall and disease specific survival rates in the CRP-positive group were significantly lower than the rates in the CRP-negative group. Based on a multivariate analysis, the preoperative serum CRP level was selected as one of the unfavorable indicators regarding survival.

Conclusion: The preoperative serum CRP level is an independent and significant indicator predictive of a poor prognosis in patients with NSCLC.

Download full-text PDF

Source

Publication Analysis

Top Keywords

preoperative serum
8
serum c-reactive
8
c-reactive protein
8
non-small cell
8
cell lung
8
lung cancer
8
protein level
4
level non-small
4
cancer unlabelled
4
unlabelled evaluated
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!